Description

11-[4-[2-(2-Hydroxyethoxy)Ethyl]-1-Piperazinyl]Dibenzo[B,F][1,4]Thiazepin-7-Ol S-Oxide is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents targeting central nervous system disorders. It is primarily sought by pharmaceutical manufacturers, biotechnology R&D laboratories, and fine chemical synthesis specialists for its role as a key building block in active pharmaceutical ingredient (API) production.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel psychotropic and neuroactive Active Pharmaceutical Ingredients (APIs).
• Medicinal Chemistry Research: Used as a core scaffold or building block for structure-activity relationship (SAR) studies in drug discovery programs.
• Biochemical Tool Compound: Serves as a reference standard or ligand in pharmacological assays and receptor binding studies.
• Fine Chemical Synthesis: Employed in custom synthesis and contract manufacturing for producing specialized, high-value chemical entities.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	11-[4-[2-(2-Hydroxyethoxy)Ethyl]-1-Piperazinyl]Dibenzo[B,F][1,4]Thiazepin-7-Ol S-Oxide
CAS No.	1185170-04-0
Molecular Formula	C23H27N3O4S
Molecular Weight	441.55 g/mol
Synonyms	11-[4-[2-(2-Hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepin-7-ol 7-oxide; Dibenzo[b,f][1,4]thiazepin-7-ol, 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-, 7-oxide; 1185170-04-0; Quetiapine Related Compound; Quetiapine Sulfoxide Derivative; Hydroxyethylpiperazinyl Dibenzo Thiazepinone S-Oxide; 7-Hydroxy-11-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)dibenzo[b,f][1,4]thiazepine 7-oxide
EINECS	Contact for details

Quality Control

Our 11-[4-[2-(2-Hydroxyethoxy)Ethyl]-1-Piperazinyl]Dibenzo[B,F][1,4]Thiazepin-7-Ol S-Oxide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets exacting standards for pharmaceutical R&D. Certificates of Analysis (COA) with complete traceability are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.